Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Urine Studies I: Urinalysis01:29

Urine Studies I: Urinalysis

Urinalysis is a widely used diagnostic test that analyzes urine's physical, chemical, and microscopic characteristics. Healthcare providers use it to detect and monitor various health conditions, including renal disease, urinary tract infections (UTIs), diabetes, and metabolic or systemic disorders.Components of UrinalysisUrinalysis consists of three primary components: physical, chemical, and microscopic examination. Each provides unique insights into the urine sample and, by extension, the...
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Evidence-Based Guidelines for the Diagnosis and Treatment of Pediatric CKD-Mineral and Bone Disorder (Version 2024).

Kidney international reports·2026
Same author

The Modified "ICTM" technique for total tongue reconstruction using profund artery perforator flap.

Plastic and reconstructive surgery·2026
Same author

[Effect of Biodegradable Mulching Film on Soil Microbial Community in Cotton Field was Revealed Based on Metagenomics].

Huan jing ke xue= Huanjing kexue·2026
Same author

Correlation analysis between sleep quality and depressive symptoms among rural elderly in China: An observational study.

World journal of psychiatry·2025
Same author

Endothelial septin 4 reduction contributes to lipopolysaccharide-induced acute lung injury by disrupting endothelial barrier integrity and promoting infiltration of ISG<sup>+</sup> cells.

International journal of biological macromolecules·2025
Same author

Earlier Hematuria Negative Conversion Was an Independent Predictor for Nephrotic Remission in Patients with Primary Membranous Nephropathy and Nephrotic Syndrome.

American journal of nephrology·2025

Related Experiment Video

Updated: May 29, 2026

Surface-enhanced Resonance Raman Scattering Nanoprobe Ratiometry for Detecting Microscopic Ovarian Cancer via Folate Receptor Targeting
07:54

Surface-enhanced Resonance Raman Scattering Nanoprobe Ratiometry for Detecting Microscopic Ovarian Cancer via Folate Receptor Targeting

Published on: March 25, 2019

Urinary rubidium in breast cancers.

Yi Su1, Li-Juan Chen, Jian-Rong He

  • 1The School of Public Health, Sun Yat-Sen University, Guangzhou, China.

Clinica Chimica Acta; International Journal of Clinical Chemistry
|September 14, 2011
PubMed
Summary

Lower urinary rubidium levels are linked to increased breast cancer risk. This study suggests rubidium may serve as a potential biomarker for breast cancer risk assessment in women.

More Related Videos

Studying Triple Negative Breast Cancer Using Orthotopic Breast Cancer Model
09:29

Studying Triple Negative Breast Cancer Using Orthotopic Breast Cancer Model

Published on: March 20, 2020

Radionuclide-fluorescence Reporter Gene Imaging to Track Tumor Progression in Rodent Tumor Models
10:04

Radionuclide-fluorescence Reporter Gene Imaging to Track Tumor Progression in Rodent Tumor Models

Published on: March 13, 2018

Related Experiment Videos

Last Updated: May 29, 2026

Surface-enhanced Resonance Raman Scattering Nanoprobe Ratiometry for Detecting Microscopic Ovarian Cancer via Folate Receptor Targeting
07:54

Surface-enhanced Resonance Raman Scattering Nanoprobe Ratiometry for Detecting Microscopic Ovarian Cancer via Folate Receptor Targeting

Published on: March 25, 2019

Studying Triple Negative Breast Cancer Using Orthotopic Breast Cancer Model
09:29

Studying Triple Negative Breast Cancer Using Orthotopic Breast Cancer Model

Published on: March 20, 2020

Radionuclide-fluorescence Reporter Gene Imaging to Track Tumor Progression in Rodent Tumor Models
10:04

Radionuclide-fluorescence Reporter Gene Imaging to Track Tumor Progression in Rodent Tumor Models

Published on: March 13, 2018

Area of Science:

  • Oncology
  • Environmental Health
  • Biochemistry

Background:

  • Rubidium is a potential anticancer agent, but its association with breast cancer risk and utility as a biomarker are unstudied.
  • No prior research has investigated rubidium levels in biological samples concerning breast cancer risk.

Purpose of the Study:

  • To investigate the association between urinary rubidium levels and breast cancer risk.
  • To evaluate the potential of urinary rubidium as a biomarker for breast cancer risk assessment.

Main Methods:

  • Collected survey data and urine specimens from 240 women with breast cancer and 246 age-matched controls.
  • Measured urinary rubidium concentrations using inductively coupled plasma mass spectrometry.

Main Results:

  • Urinary rubidium levels were significantly lower in breast cancer cases compared to controls.
  • Higher urinary rubidium levels showed a dose-dependent inverse association with breast cancer risk.
  • The area under the receiver-operating-characteristic curve indicated potential for rubidium as a biomarker.

Conclusions:

  • Urinary rubidium levels are inversely associated with breast cancer risk.
  • Urinary rubidium shows promise as a biomarker for breast cancer risk assessment.